Gene: NADK
Official Full Name: NAD kinaseprovided by HGNC
Gene Summary: NADK catalyzes the transfer of a phosphate group from ATP to NAD to generate NADP, which in its reduced form acts as an electron donor for biosynthetic reactions (Lerner et al., 2001 [PubMed 11594753]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15899 | NADK Knockout cell line (HeLa) | Human | NADK | 1:3~1:6 | Negative | Online Inquiry |
KO15900 | NADK Knockout cell line (HCT 116) | Human | NADK | 1:2~1:4 | Negative | Online Inquiry |
KO15901 | NADK Knockout cell line (HEK293) | Human | NADK | 1:3~1:6 | Negative | Online Inquiry |
KO15902 | NADK Knockout cell line (A549) | Human | NADK | 1:3~1:4 | Negative | Online Inquiry |
NADK Gene Knockout Cell Lines are genetically modified cellular models designed to study the function of the NAD kinase (NADK) gene, which plays a critical role in cellular metabolism by regulating the balance of nicotinamide adenine dinucleotide (NAD) and its phosphate form (NADP). By utilizing CRISPR-Cas9 technology, these cell lines exhibit a complete knockout of the NADK gene, providing researchers with a unique platform to explore the metabolic pathways influenced by NADK activity.
The primary mechanism of action involves the disruption of NADK protein synthesis, leading to altered cellular NAD/NADP ratios. This change impacts various biological processes, including oxidative stress response, energy metabolism, and the biosynthesis of critical biomolecules. By simulating the loss of NADK function, scientists can investigate the gene's contributions to cellular homeostasis and its implications in diseases such as cancer and metabolic disorders.
In the context of research and clinical applications, NADK Gene Knockout Cell Lines are invaluable for dissecting the underlying mechanisms of NAD metabolism and its connections to broader pathophysiological states. These models are particularly beneficial for drug discovery initiatives, where the modulation of NADK activity could present novel therapeutic targets.
Unlike other gene knockout models, our NADK Gene Knockout Cell Lines offer unparalleled precision in gene editing, ensuring reliable and reproducible results. They provide a comprehensive toolkit for both basic research and clinical exploration, giving users the ability to conduct high-throughput screenings and elucidate complex metabolic pathways with confidence.
For researchers and clinicians invested in metabolic research, the NADK Gene Knockout Cell Lines represent a vital resource that combines scientific rigor with practical utility. They facilitate deeper insights into disease mechanisms while paving the way for innovative therapeutic strategies. With our cutting-edge genetic engineering expertise and commitment to quality, we stand at the forefront of delivering advanced biological products that empower the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.